1XZ Stock Chart & Stats
€0.70
€0.03(4.15%)
At close: 4:00 PM EDT
€0.70
€0.03(4.15%)
Day’s Range― - ―
52-Week Range€0.61 - €2.02
Previous CloseN/A
Volume0.00
Average Volume (3M)65.00
Market Cap
€1.36B
Enterprise Value€6.58B
Total Cash (Recent Filing)€7.20B
Total Debt (Recent Filing)€29.05M
Price to Earnings (P/E)21.3
Beta0.60
Next Earnings
Mar 16, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding2,161,443,600
10 Day Avg. Volume4
30 Day Avg. Volume65
Financial Highlights & Ratios
PEG Ratio0.50
Price to Book (P/B)2.63
Price to Sales (P/S)4.77
P/FCF Ratio66.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.28Price Target Upside82.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.02
Revenue Forecast (FY)€563.71M
Bulls Say, Bears Say
Bulls Say
Profitability TurnaroundThe shift from recurring losses to positive and stronger net income indicates a meaningful improvement in the operating model. If maintained, profitability can support reinvestment, strengthen resilience, and provide a more durable foundation for the healthcare platform’s future growth.
Conservative Balance SheetExtremely low leverage reduces financial risk and preserves flexibility during periods of changing healthcare demand. A lightly indebted balance sheet also leaves more capacity to fund platform development or absorb volatility without substantial interest or refinancing pressure.
Improving Cash GenerationThe move to positive operating and free cash flow, with further strengthening in 2025, improves the quality and self-funding potential of the earnings recovery. Stronger internal cash generation can support investment and reduce reliance on external financing over the medium term.
Bears Say
Volatile Revenue TrajectoryThe uneven revenue path makes the company’s growth outlook less predictable even as profitability improves. Sharp prior contractions can weaken operating leverage and make it harder to plan investment, demonstrate sustained customer adoption, or compound earnings consistently.
Uneven Cash ConversionDespite recent positive free cash flow, the history of deep outflows and relatively low coverage suggests reported earnings may not always translate smoothly into cash. Continued sensitivity to working-capital or non-cash swings could constrain dependable funding for expansion.
Equity Base VolatilityA large change in reported equity introduces uncertainty around the evolution of the capital base and makes balance-sheet trends harder to interpret. Even with minimal debt, such volatility can complicate assessment of returns, capitalization, and long-term financial stability.
Ping An Healthcare and Technology Company News
1XZ FAQ
What was Ping An Healthcare and Technology Company Limited’s price range in the past 12 months?
Ping An Healthcare and Technology Company Limited lowest stock price was €0.61 and its highest was €2.02 in the past 12 months.
What is Ping An Healthcare and Technology Company Limited’s market cap?
Ping An Healthcare and Technology Company Limited’s market cap is €1.36B.
When is Ping An Healthcare and Technology Company Limited’s upcoming earnings report date?
Ping An Healthcare and Technology Company Limited’s upcoming earnings report date is Mar 16, 2027 which is in 141 days.
How were Ping An Healthcare and Technology Company Limited’s earnings last quarter?
Ping An Healthcare and Technology Company Limited released its earnings results on Aug 19, 2026. The company reported €0.013 earnings per share for the quarter.
Is Ping An Healthcare and Technology Company Limited overvalued?
According to Wall Street analysts Ping An Healthcare and Technology Company Limited’s price is currently Undervalued.
Does Ping An Healthcare and Technology Company Limited pay dividends?
Ping An Healthcare and Technology Company Limited does not currently pay dividends.
What is Ping An Healthcare and Technology Company Limited’s EPS estimate?
Ping An Healthcare and Technology Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ping An Healthcare and Technology Company Limited have?
Ping An Healthcare and Technology Company Limited has 2,161,443,600 shares outstanding.
What happened to Ping An Healthcare and Technology Company Limited’s price movement after its last earnings report?
Ping An Healthcare and Technology Company Limited reported an EPS of €0.013 in its last earnings report. Following the earnings report the stock price went down -3.738%.
Which hedge fund is a major shareholder of Ping An Healthcare and Technology Company Limited?
Currently, no hedge funds are holding shares in DE:1XZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ping An Healthcare and Technology Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€1.28 (82.85% Upside)
€1.28 (82.85% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.03%
12-Months-Change
Fundamentals
Return on Equity
4.62%
Trailing 12-Months
Asset Growth
6.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ping An Healthcare and Technology Company Limited
Ping An Healthcare and Technology Company Limited (PAHT), through its subsidiaries, operates a comprehensive online platform that delivers healthcare services across the People's Republic of China. Its core offerings encompass virtual medical consultations, facilitated hospital referrals and appointment scheduling, inpatient care coordination, and expert second opinions. PAHT also provides standardized consumer healthcare packages, integrating services from a network of medical institutions. Beyond services, the company offers a broad array of products, including pharmaceuticals, health supplements, medical devices, wellness items such as fitness equipment and personal care products, and other miscellaneous goods. Furthermore, PAHT engages users with health management and wellness interaction services, featuring various programs, interactive tools, activities, and personalized content. Its additional operations include medicine marketing, technology services, application development and maintenance, direct hospital and clinic services, and the management of an insurance agency. Established in 2014, Ping An Healthcare and Technology Company Limited maintains its headquarters in Shanghai, China.
1XZ Company Deck
1XZ Earnings Call
Q2 2026
0:00 / 0:00
1XZ Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€1.28
▲(82.85% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Dingdang Health Technology Group Ltd.
―
Perfect Medical Health Management Limited
―
Yidu Tech, Inc.
―
Medlive Technology Co., Ltd.
―
Xunfei Healthcare Technology Co., Ltd.
―







